Herpes Zoster
Conditions
Keywords
Spain, cost, complications, incidence, adults, quality of life, Herpes Zoster, Surveillance
Brief summary
The purpose of this study is to collect data on the incidence, complications and impact on quality of life of herpes zoster (HZ) disease in adults \>=50 years of age in Spain. This study will also collect data on costs related to the HZ disease, especially postherpetic neuralgia (PHN)
Interventions
OTHERData collection
HZ and PHN booklet questionnaire and zoster brief pain inventory (ZBPI) questionnaire.
Sponsors
GlaxoSmithKline
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* A male or female \>=50 years of age at the time of study enrolment presenting with acute HZ; * HZ diagnosis for this HZ episode; * is the subject's first outpatient diagnosis; OR * took place at another site/ centre up to seven days before the initial visit for the present study; * Ability to comply with study procedures\*; * Written informed consent obtained from the subject\*. Note: \* will be applicable to secondary objectives only and not for the primary objective to calculate incidence.
Exclusion criteria
• Subject participating in another research study. Note: This
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total number of HZ cases as recorded per participating practice, overall and within a specific age group and gender. | up to one year |
Secondary
| Measure | Time frame |
|---|---|
| Anamnestic information, clinical parameters and complications related to HZ. | Between Day 0 and Day 270 |
| Direct medical, direct non-medical and indirect costs related to HZ. | Between Day 0 and Day 90 |
| Pain assessment in HZ subjects. | At Day 90 |
| Occurrence of PHN, i.e. persistence of HZ-related pain. | 90, 180, and 270 days after onset of HZ. |
| Direct medical, direct non-medical and indirect costs related to PHN. | At Day 90, Day 180 and Day 270 |
| Pain assessment in PHN subjects. | At Day 90, Day 180 and Day 270 |
| Quality of life assessment in PHN subjects. | At Day 90, Day 180 and Day 270 |
| Quality of life assessment in HZ subjects | Day 15, Day 30, Day 60 and Day 90 |
Countries
Spain
Outcome results
None listed